PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1326532
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1326532
Global Lancets Market is valued approximately at USD XXX billion in 2022 and is anticipated to grow with a growth rate of more than XX% over the forecast period 2023-2030. Lancets is a medical instrument used to obtain blood samples for disease diagnosis, especially in diabetes. It has a double-edged blade that punctures the skin, and it is disposable. Lancets are commonly used by diabetic patients to monitor their blood glucose levels and also in clinics and labs for blood group confirmation. The lancets market is experiencing significant growth due to the growing prevalence of chronic diseases such as diabetes, hyperlipidemia, and dyslipidemia. The market is driven by the growing use of disposable blood lancets for painless diagnosis of blood sugar level, hemoglobin, fat level, and other important blood components. The use of disposable lancets reduces the risk of blood transfusion and infection in transmission, further contributing to the market growth.
The growing geriatric population, coupled with a rising incidence of diabetes, is creating demand for lancets. According to the International Diabetes Federation in 2021, there are about 537 million adults (aged 20-79 years) living with diabetes globally in 2021. By 2030, it is projected that the number increased to 643 million, and by 2045, it is expected to reach 783 million. According to the World Bank Group, the world geriatric population was 727 million in 2020, and it is predicted to sustain over the next three decades, reaching 1.5 million in 2050. Additionally, increasing demand in home healthcare equipment and improved medical device regulation and the expansion of the blood lancets is anticipated to create the lucrative opportunity for the market growth. However, low awareness regarding homecare lancet in developing countries stifles the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Lancets Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the expanding geriatric population , increasing targeted population, increased R&D costs, and growing knowledge about diabetes therapy. According to the International Diabetes Federation Diabetes Atlas Tenth Edition in 2021, about 32.2 million persons in the United States had diabetes in 2021, with a predicted increase to 36.3 million by 2045. Asia Pacific is expected to grow at fastest growth rate during the forecast period, owing to due to improving healthcare infrastructure and a large patient pool in need of diagnostic tests for treatment. Additionally, the rising incidence of infectious diseases such as dengue, Zika, West Nile, malaria, and chikungunya is contributing to the increased demand for lancing devices.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
List of tables and figures are dummy in nature, final lists may vary in the final deliverable